Reem Suliman

7PUBLICATIONS

21CO-AUTHORS

Traditional Chinese medicine and treatmentsEpidemiological methodsFood properties (incl. characteristics and health benefits)Regenerative medicine (incl. stem cells)Glycoconjugates

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|May 19, 2026

Efficacy, Safety, and Tolerability of Atogepant in Migraine Patients from the UAE.

|Apr 09, 2026

Migraine Patients Treated With Erenumab and the Risk of Hypertension: A Registry-Based Real-World Study.

Christian Lampl, Reem Suliman, Viktoria Tischler-Strasser

|Jul 30, 2025

A randomized open-label study to evaluate the effectiveness and safety of once-daily rimegepant 75 mg orally disintegrating tablet for the short-term preventive treatment of fasting-triggered headache in individuals with migraine.

Taoufik Alsaadi, Reem Suliman, Jiyue Yang

|Feb 29, 2024

Impacts of chitosan and its nanoformulations on the metabolic syndromes: a review.

M E Abd El-Hack, M Kamal, R S Alazragi

|Feb 23, 2024

Effectiveness of Switching CGRP Monoclonal Antibodies in Non-Responder Patients in the UAE: A Retrospective Study.

Reem Suliman, Vanessa Santos, Ibrahim Al Qaisi

|Feb 16, 2024

Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study.

Taoufik Alsaadi, Reem Suliman, Vanessa Santos

Pageof 2

Frequent Collaborators

Taoufik Alsaadi

M E Abd El-Hack

M Kamal

R M Alreemi

A Qadhi

K Ghafouri

W Azhar

A M Shakoori

N Alsaffar

H M Naffadi

Frequent Collaborators

Taoufik Alsaadi

M E Abd El-Hack

M Kamal

R M Alreemi